Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents
Gels · 05.01.2024 · 10 (1) · 44
DOI: 10.3390/gels10010044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gels, online erschienen am 05.01.2024. Verfasst von Elena O Bakhrushina und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov Universit…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Implantation is a modern method of administering chemotherapeutic agents, with a highly targeted effect and better patient tolerance due to the low frequency of administration. Implants are capable of controlled release, which makes them a viable alternative to infusional chemotherapy, allowing patients to enjoy a better quality of life without the need for prolonged hospitalization. Compared to subcutaneous implantation, intratumoral implantation has a number of significant advantages in terms of targeting and side effects, but this area of chemotherapy is still poorly understood in terms of clinical trials. At the same time, there are more known developments of drugs in the form of implants and injections for intratumoral administration. The disadvantages of classical intratumoral implants are the need for surgical intervention to install the system and the increased risk of tumor rupture noted by some specialists. The new generation of implants are in situ implants—systems formed in the tumor due to a phase transition (sol–gel transition) under the influence of various stimuli. Among this systems some are highly selective for a certain type of malignant neoplasm. Such systems are injected and have all the advantages of intratumoral injections, but due to the phase transition occurring in situ, they form depot forms that allow the long-term release of chemotherapeutic agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia.
- Department of Pharmacology, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia.
- Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia.
- Clinical Center VitaMed, Moscow 125319, Russia.
- Department of Analytical, Physical and Colloidal Chemistry, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia.
Zitieren
APA
Bakhrushina, E. O., Mikhel, I. B., Buraya, L. M., Moiseev, E. D., Zubareva, I. M., Belyatskaya, A. V., Evzikov, G. Y., Bondarenko, A. P., Krasnyuk, I. I., & Krasnyuk, I. I. (2024). Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents. Gels, 10(1), 44. https://doi.org/10.3390/gels10010044
Vancouver
Bakhrushina EO, Mikhel IB, Buraya LM, Moiseev ED, Zubareva IM, Belyatskaya AV, et al. Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents. Gels. 2024;10(1):44. doi:10.3390/gels10010044
BibTeX
@article{Bakhrushina2024,
author = {Bakhrushina, Elena O and Mikhel, Iosif B and Buraya, Liliya M and Moiseev, Egor D and Zubareva, Irina M and Belyatskaya, Anastasia V and Evzikov, Grigory Y and Bondarenko, Alexey P and Krasnyuk, Ivan I and Krasnyuk, Ivan I},
title = {Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents},
journal = {Gels},
year = {2024},
volume = {10},
number = {1},
pages = {44},
doi = {10.3390/gels10010044}
}
EUVIMED